In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
Request InsightsPurchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively. Request Insights
IN THE NEWSFebruary 2, 2021: AccuVein Inc. announced that the Infusion Nurses Society (INS) recommends the use of NIR vein visualization technology for venipuncture procedures, to help in vein selection by assessing peripheral venous systems.
July 23, 2020: ZD Medical Inc. upgraded its Vein Finder System- Vascular Positioning to provide more effective vein visualization solutions.
The global vein illuminator device market is estimated to garner significant revenue by the end of 2031 by growing at a CAGR of ~30% over the forecast period, i.e., 2022 – 2031. Further, the market generated modest revenue in the year 2021. The growth of the market can be attributed to the rising geriatric population and the increasing prevalence of chronic conditions among the population. It was observed that about 16 million deaths were caused by cardiovascular diseases, cancer caused around 9000 deaths while due to respiratory diseases, approximately 4000 people died in 2019, A higher prevalence was found among women, older adults, and rural residents.
Get more information on this report: Request Sample PDF
It is difficult to find veins in patients with fragile skin, especially elders, babies, and obese patients. Therefore, this creates the need for a vein illuminator device that enables doctors and nurses to locate veins in patients for venipuncture and blood draw. The vein illuminator uses NIR (near-infrared) imaging to detect veins accurately under the skin. Furthermore, the increasing number of surgical procedures and the consequent rise in the need for intravenous (IV) therapy after surgery is expected to drive the global vein illuminator device market during the forecast period. For instance, there are about 300 million major surgical procedures performed worldwide each year. Other factors, including growing healthcare expenditure, increasing public spending on healthcare services, and the emergence of advanced vein illuminator devices are further estimated to enlarge the global vein illuminator device market size during the forecast period.
Anemia, which is a major global health concern, is known to primarily affect children and pregnant women. A staggering 42% of children less than 5 years old and 40% of pregnant women are stated to be living with anemia across the globe.
The rising cases of blood diseases such as anemia, leukocytosis, and hemophilia requires lengthy blood treatment regimens which is expected to fuel the demand for vein illuminator devices over the forecast period.
Between 2008 to 2018, voluntary unpaid blood donations increased by 10.7 million. Worldwide, 118.5 million blood donations are collected. The majority of these are collected in high-income countries. Over 13,300 blood donation centers in 169 countries report collecting 106 million donations in total.
According to Centers for Medicare & Medicaid Services, the federal government financed the largest share of total health spending (36.3 %), followed by households (26.1 %). State and local governments accounted for 14.3 percent of total health care spending, while private businesses accounted for 6.5 percent.
According to Centers for Disease Control and Prevention the prevalence of obesity in the US increased from 30.5% in 1999-2000 to 41.9% in 2017-2020. A similar increase of 4.7% in the prevalence of severe obesity occurred during the same period.
The market is segmented by technology into transillumination, near-infrared, and ultrasound. Out of these, the transillumination segment is anticipated to capture the largest market size in the global vein illuminator device market on account of extensive usage of the transillumination vein locators for peripheral venous line procedures. It is observed, that the success rate of cannulation was significantly higher in the US group (~80%) than in the Veinlite group (~55%), about 90% of the US group and around 80% of the Veinlite group achieved good overall success rates. Moreover, the adoption of this technology is rapidly increasing owing to its benefits, including less pain, precise vein identification, and reduced risk of bruising and bleeding. Therefore, these technological benefits are expected to contribute to segment growth over the forecast period.
Get more information on this report: Request Sample PDF
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Regionally, the global vein illuminator device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is estimated to hold the largest market share by the end of 2031 on the back of the strong healthcare industry and increasing healthcare expenditure in the region. According to data released by the Centers for Medicare & Medicaid Services, United States health care expenditure reached USD 4.1 trillion in 2020. In addition, the demand for vein illuminators is expected to grow over the forecast period owing to the increasing geriatric population in the region as well as the large usage of vein illuminators during venipuncture. According to the data provided by World Bank, the geriatric population in United States is stated to reach 56,545,938 in 2021. Furthermore, the presence of major established market players in the region is also projected to drive the vein illuminator devices market during the forecast period
Get more information on this report: Request Sample PDF
The global vein illuminator device market is further classified on the basis of region as follows:
Our in-depth analysis of the global vein illuminator device market includes the following segments:
|
By Technology |
|
|
|
|
|
|
By Application |
|
|
|
|
|
|
|
|
By End User |
|
|
|
|
|
|
|
|
|
|
FREQUENTLY ASKED QUESTIONS
Rising incidences of chronic conditions and blood borne diseases are major factors driving the growth of the vein illuminator device market.
The market is anticipated to attain a CAGR of ~30% over the forecast period, i.e., 2022 – 2031.
High cost associated with product and lack of awareness vein illuminator device of among people are expected to hamper the market growth.
The market in North America is projected to hold the largest market share by the end of 2031 and provide more business opportunities in the future.
The major players in the market are Qingdao Bright Medical Manufacturing Co Ltd, Ibis Medical Equipment & Systems Pvt. Ltd., Venoscope, LLC, Christie Medical Holdings, Inc., Sharn Anesthesia, Inc., TransLite, LLC., AimVein, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by technology, application, end user and by region.
The transillumination segment is anticipated to garner the largest market size by the end of 2031 and display significant growth opportunities.
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions | LOB
Copyright © 2022 Research Nester. All Rights Reserved
